Drreddys Laboratories reported $6.17B in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ani Pharmaceuticals ANIP:US $ 189.52M 20.54M
Aphria Inc APH:CN C$ 901.16M 375.72M
Aurora Cannabis Inc ACB:CN 358.61M 49.11M
Bayer BAYN:GR € 36664M 1254M
Canopy Growth Corp WEED:CN C$ 1.64B 33.23M
Catalent CTLT:US $ 3166M 16.4M
Corcept Therapeutics CORT:US $ 0M 0M
Drreddys Laboratories RDY:US $ 6166M 133M
Endo International Ordinary Shares ENDP:US $ 8074.44M 26.54M
GlaxoSmithKline GSK:LN 20442M 2605M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Hikma Pharmaceutical HIK:LN 751M 13M
Horizon Pharma HZNP:US $ 2560.44M 2.07M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Lannett LCI:US $ 590.68M 20.02M
Lonza Group LONN:SW 2.79B 5M
Novartis NOVN:VX SF 26491M 908M
Pacira Pharmaceuticals PCRX:US $ 321.71M 4.37M
Phibro Animal Health PAHC:US $ 382.71M 25.92M
Prestige Brands PBH:US $ 1551.51M 65.04M
Richter Gedeon RICHT:HB 10.93B 10.93B
Supernus Pharmaceuticals SUPN:US $ 370.38M 14.15M
Teva Pharmaceutical TEVA:IT 21.6B 686M